α1-微球蛋白(a1M)活性蛋白
Active Alpha-1-Microglobulin (a1M)
AMBP; UTI; HCP; EDC1; HI30; IATIL; ITILC; ITI; ITIL; Alpha 1 Microglobulin/Bikunin Precursor; Growth-inhibiting protein 19; Uristatin; Uronic-Acid-Rich Protein; Trypstatin
- 編號(hào)APA217Hu61
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份磷酸鹽緩沖液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)5.8
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1704 ¥ 4260 ¥ 8520 ¥ 25560 ¥ 63900
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
SDS-PAGE圖
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
活性實(shí)驗(yàn)
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APA217Hu61 | α1-微球蛋白(a1M)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA217Hu62 | α1-微球蛋白(a1M)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA217Hu61 | α1-微球蛋白(a1M)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA217Hu62 | α1-微球蛋白(a1M)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA217Hu01 | α1-微球蛋白(a1M)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA217Hu01 | α1-微球蛋白(a1M)多克隆抗體 | WB |
| LAA217Hu71 | α1-微球蛋白(a1M)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA217Hu22 | α1-微球蛋白(a1M)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA217Hu | α1-微球蛋白(a1M)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA217Hu | α1-微球蛋白(a1M)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA217Hu | α1-微球蛋白(a1M)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Diabetes Technology & Therapeutics | Proteomic Identification of Human Urinary Biomarkers in Diabetes Mellitus Type 2 [Liebert: 20100078] |
| Journal of Pharmaceutical and Biomedical Analysis | Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2 [PubMed: 21130593] |
| BioMed Research International | Proteomic Profiling for Peritoneal Dialysate: Differential Protein Expression in Diabetes Mellitus [PubMed: PMC3679811] |
| Mainz | Identifizierung neuer potentieller Biomarker für das Kolonkarzinom sowie dessen Vorstufen [Info:Source] |
| Cellular Physiology and Biochemistry | Activated Α7nachr Improves Postoperative Cognitive Dysfunction and Intestinal Injury Induced by Cardiopulmonary Bypass in Rats: Inhibition of the Proinflammatory?… [Pubmed:29672286] |
| Journal of Clinical Medicine | Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients [Pubmed: 30486327] |
留言咨詢
